Nucleic Acid Isolation and Purification Market
Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Plasmid DNA, microRNA), Sample Type (Cellular, FFPE, CfDNA/CtDNA), Application, End User, Competition - Global Forecast to 2031
NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SIZE, SHARE & GROWTH SNAPSHOT
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global nucleic acid isolation and purification market is projected to grow from USD 6.37 billion in 2026 to USD 9.66 billion by 2031, at a CAGR of 8.7% during the forecast period. The market was valued at USD 6.08 billion in 2025. Nucleic acid isolation and purification is a foundational step in modern molecular biology and clinical testing, enabling the extraction of high-quality DNA and RNA from blood, tissues, cells, and other biological samples for downstream analysis. It is predominantly used in fields such as molecular diagnostics, infectious disease testing, oncology, genetic disorder screening, reproductive health, biopharmaceutical research, and academic genomics. Market growth is primarily driven by the rising adoption of automated nucleic acid extraction systems, the increasing need for high-purity, inhibitor-free nucleic acid recovery, and growth in the processing of complex and difficult sample types.
KEY TAKEAWAYS
-
BY REGIONThe Asia Pacific is the fastest-growing regional segment at a CAGR of 9.6% during the forecast period.
-
BY PRODUCTThe kits segment, among products, is projected to grow at the highest CAGR of 9.3% between 2026 and 2031.
-
BY METHODThe magnetic bead-based isolation and purification method accounted for 39.1% of the market in 2025.
-
BY TYPEThe plasmid DNA isolation and purification segment is expected to dominate the global nucleic acid isolation and purification market in 2025.
-
BY SAMPLE TYPEThe cell-free samples segment is expected to grow at the highest CAGR over the forecast period.
-
BY APPLICATIONPersonalized Medicine segment is expected to grow at highest CAGR over the forecast period.
-
BY END USERHospitals & diagnostic centers dominated the global nucleic acid isolation and purification market in 2025.
-
COMPETITIVE LANDSCAPE - KEY PLAYERSThermo Fisher Scientific, Inc., QIAGEN N.V., and Merck KGaA were identified as some of the star players in the global nucleic acid isolation and purification market, given their strong market shares and product footprints.
-
COMPETITIVE LANDSCAPE - STARTUPSFavorgen Biotech Corporation and Omega Bio-Tek, Inc. have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.
The global nucleic acid isolation and purification market is expanding for several reasons. These include the growing adoption of molecular diagnostics, increased use of PCR and NGS in clinical and research workflows, rising demand for liquid biopsy and precision medicine applications, and the shift toward automated extraction platforms. The market is also supported by the need for high-purity DNA/RNA recovery from complex sample types, such as FFPE, cfDNA, microbiome, and pathogen samples, as well as stricter quality and validation requirements across clinical diagnostics, biopharma, and research laboratories.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The nucleic acid isolation and purification market is shifting, with revenue generation evolving in response to changing customer expectations and downstream impact. At the core, the market is transitioning from traditional, low-value consumables (basic extraction kits and reagents) to high-value, integrated, and automation-driven solutions. This shift is primarily driven by the evolving needs of key customers, including diagnostic labs, research institutes, and biopharma companies, which are increasingly focused on improving the efficiency, scalability, and reliability of molecular workflows. As a result, their priorities have moved toward automation, standardization, faster turnaround times, compatibility with advanced technologies such as PCR and NGS, and regulatory compliance. These changing imperatives are directly shaping the future revenue mix of nucleic acid isolation and purification providers, pushing them to offer automated extraction systems, premium application-specific kits, and integrated workflow solutions rather than standalone products. The focus is now on building ecosystems that combine instruments, consumables, and software, enabling recurring revenue and stronger customer retention. Ultimately, these changes are driven by the need to deliver better outcomes at the end-user level. Improved nucleic acid isolation and purification workflows enable faster and more accurate diagnostics, better clinical decisions, scalable genomic testing, and higher success rates in biopharma research and CGT manufacturing.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Rising adoption of automated nucleic acid extraction systems
-
Increasing need for high-purity and inhibitor-free nucleic acid recovery
Level
-
Price pressure and partial commoditization of routine extraction kits
-
Continued use of manual and low-cost in-house methods in small & mid-sized labs
Level
-
Premium extraction solutions for low-input and cell-free nucleic acids
-
Expansion of automated benchtop and mid-throughput extraction platforms
Level
-
Pre-analytical variability that affects extraction output
-
Removal of inhibitors and contaminants from difficult matrices
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Rising adoption of automated nucleic acid extraction systems
Automation is becoming a core purchasing criterion in the nucleic acid isolation and purification market as laboratories are expected to process higher sample volumes with faster turnaround times and less reliance on skilled manual handling. In molecular diagnostics, hospital labs, public health labs, biopharma R&D, and genomic testing centers, manual extraction is increasingly seen as a bottleneck because it can increase variability, contamination risk, and labor burden. Automated systems help standardize workflows, improve reproducibility, and support scale-up from routine testing to high-throughput processing. This is especially relevant for applications such as PCR, qPCR, NGS, liquid biopsy, and infectious disease testing, where consistency in pre-analytical processing directly affects downstream accuracy. Thermo Fisher reports that its KingFisher systems can process up to 96 samples per run and isolate RNA or DNA from a 96-well plate in about 25 minutes, underscoring why automation is gaining strong traction in routine and high-volume settings.
Restraint: Price pressure and partial commoditization of routine extraction kits
Price pressure is intensifying in the nucleic acid isolation and purification market, particularly for routine extraction kits used in standard applications such as PCR, qPCR, and basic molecular biology workflows. As these kits become widely available from multiple vendors, differentiation in core chemistry has diminished, leading to partial commoditization. Buyers, especially academic and diagnostic labs in cost-sensitive regions, as well as large testing facilities, are increasingly comparing products by price per sample rather than by brand loyalty. This has led to competitive pricing strategies, bulk discounts, and more frequent tender-based procurement.
Opportunity: Premium extraction solutions for low-input and cell-free nucleic acids
A major opportunity in this market is the growing demand for premium extraction solutions for low-input and cell-free nucleic acids, especially in liquid biopsy, prenatal screening, transplant monitoring, and residual disease testing. These applications involve very small amounts of fragmented DNA or RNA, so routine extraction kits are often insufficient. Laboratories need kits that deliver both high recovery efficiency and high purity, enabling suppliers to position these products at premium prices. This makes the segment commercially attractive compared with standard extraction kits, where pricing pressure is much higher.
Challenge: Pre-analytical variability that affects extraction output
One of the biggest challenges in the nucleic acid isolation and purification market is pre-analytical variability, which can significantly affect extraction yield, purity, and reproducibility. Pre-analytical factors include how a sample is collected, transported, stored, and processed before extraction. Variations in sample handling, such as processing delays, temperature fluctuations, repeated freeze-thaw cycles, differences in anticoagulants or preservatives, and inconsistent input volume, can all affect the quality and integrity of DNA or RNA. This is especially critical for RNA, cell-free nucleic acids, and other low-abundance targets that are highly sensitive to degradation.
NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Provides KingFisher automated extraction systems, MagMAX kits, and PureLink purification solutions used across molecular diagnostics, genomics, infectious disease testing, and biopharma research | Enables high-throughput, reproducible DNA/RNA extraction with reduced manual handling and better compatibility with PCR, qPCR, and NGS workflows |
 |
Offers QIAamp, DNeasy, RNeasy, QIAcube, EZ2 Connect, and QIAsymphony platforms for clinical diagnostics, oncology, liquid biopsy, microbiome, and research workflows | Improves sample standardization, supports complex sample processing such as FFPE and cfDNA, and strengthens automation-driven workflow efficiency |
 |
Provides MagNA Pure systems and High Pure kits for automated nucleic acid extraction in clinical molecular diagnostics and infectious disease testing laboratories | Supports reliable, regulated, and standardized extraction workflows with strong integration into downstream molecular testing platforms |
 |
Offers Maxwell automated extraction systems and ReliaPrep/Wizard kits for research, clinical, forensic, and biopharma applications | Reduces hands-on time, improves consistency, and supports flexible extraction from diverse sample types including FFPE, blood, cells, and viral samples |
 |
Through Beckman Coulter and Cytiva, provides Biomek automation platforms, AMPure XP/SPRI bead chemistries, and sample-prep solutions for NGS, genomics, and high-throughput research | Enables scalable sample preparation, efficient cleanup, and workflow automation for sequencing and advanced molecular research applications |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The nucleic acid isolation and purification market encompasses a diverse ecosystem of stakeholders, including product manufacturers, reagent and consumable suppliers, instrument providers, distributors, and end users such as pharmaceutical and biotechnology companies, diagnostic laboratories, academic and research institutions, hospitals, CROs, CDMOs, and government laboratories. Manufacturers develop, produce, and supply nucleic acid isolation and purification solutions, ranging from manual extraction kits, magnetic beads, spin columns, reagents, and buffers to automated sample preparation systems and high-throughput purification instruments. These products are widely used across applications such as molecular diagnostics, PCR/qPCR, next-generation sequencing, genomics research, infectious disease testing, oncology research, drug discovery, biobanking, and forensic analysis. Companies operating in this ecosystem must comply with applicable regulatory requirements and quality standards to ensure product accuracy, reproducibility, safety, and reliability. Regulatory and quality oversight is critical to maintaining the integrity of the nucleic acid isolation and purification supply chain, from raw material sourcing and product development to manufacturing, distribution, and end use in clinical, research, and industrial workflows.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Global Nucleic Acid Isolation and Purification Market, by Product
In 2025, the kits segment dominated the nucleic acid isolation and purification market due to their ease of use in applications such as molecular diagnostics, gene sequencing, and gene cloning, as well as the ongoing focus of key market players on developing and launching advanced kits.
Nucleic Acid Isolation and Purification Market, by Method
In 2025, the magnetic bead-based isolation and purification segment held the largest share of the nucleic acid isolation and purification market. This dominance can be attributed to its high compatibility with automated and high-throughput workflows, enabling faster processing, reduced manual intervention, and improved reproducibility.
Nucleic Acid Isolation and Purification Market, by Type
In 2025, the plasmid DNA isolation and purification segment held the largest share and will be the fastest-growing segment in the global nucleic acid isolation and purification market. This dominance is driven by the availability of a broad range of kits for plasmid DNA extraction and processing, and by the increasing application of plasmid DNA in gene expression profiling and its wide use in a variety of downstream applications.
Nucleic Acid Isolation and Purification Market, by Sample Type
In 2025, cellular samples dominated the market due to their widespread use in infectious disease testing, genomic research, cell biology, drug discovery, and molecular diagnostics, where nucleic acid extraction is a foundational upstream step.
Nucleic Acid Isolation and Purification Market, by Application
In 2025, the diagnostics segment accounted for the largest share of the global nucleic acid isolation and purification market. This dominance can be attributed to the rising application of DNA and RNA isolation for pathogen identification in routine sample processing, increasing awareness of genomic diagnostics among patients, and the growing efficiency of genomic sequencing in disease diagnosis.
Nucleic Acid Isolation and Purification Market, by End User
In 2025, hospitals and diagnostic centers accounted for the largest share of the global nucleic acid isolation and purification market. The growing importance of nucleic acid testing in molecular diagnostics is expected to drive this segment's growth over the forecast period.
REGION
Asia Pacific to be fastest-growing region in market during forecast period
Asia Pacific is likely to be the fastest-growing region in the global nucleic acid isolation and purification market, fueled by the rapid expansion of healthcare infrastructure in China, India, and Japan. Additionally, an increasing patient population suffering from chronic diseases, a rising number of testing facilities, and the implementation of awareness campaigns and conferences on nucleic acid isolation and purification contributed to this trend.
NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY EVALUATION MATRIX
Thermo Fisher Scientific is a prominent leader in the global nucleic acid isolation and purification market, backed by a comprehensive range of extraction kits, purification reagents, magnetic bead-based chemistries, automated sample preparation devices, and integrated molecular biology workflows. Its validated solutions are trusted by pharmaceutical and biotech firms, diagnostic labs, academic research centers, CROs, and government labs for DNA and RNA extraction in applications like PCR/qPCR, NGS, molecular diagnostics, infectious disease testing, oncology research, and biobanking. Meanwhile, Bio-Rad Laboratories is gaining ground as a strong competitor, expanding its sample preparation and molecular biology product lineup. Their nucleic acid extraction and purification solutions enable reliable sample processing in research, clinical, and applied testing workflows. As they grow in PCR, ddPCR, genomics, and life science research, Bio-Rad’s market relevance increases, especially among research labs, diagnostic entities, and academic institutions seeking dependable, workflow-compatible solutions.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Thermo Fisher Scientific Inc. (US)
- Qiagen N.V. (Netherlands)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Merck KGaA (Germany)
- Danaher Corporation (US)
- Promega Corporation (US)
- Agilent Technologies, Inc. (US)
- Bio-rad Laboratories, Inc. (US)
- illumina, inc. (US)
- Takara Bio Inc. (Japan)
- New England Biolabs (US)
- A&A biotechnology (Poland)
- Revvity, Inc. (US)
- Bioneer Corporation (South Korea)
- HiMedia Laboratories Pvt. Ltd. (India)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) | USD 6.08 Billion |
| Market Forecast in 2031 (Value) | USD 9.66 Billion |
| Growth Rate | CAGR of 8.7% from 2026–2031 |
| Years Considered | 2024–2031 |
| Base Year | 2025 |
| Forecast Period | 2026–2031 |
| Units Considered | Value (USD Million/Billion) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East, Africa |
WHAT IS IN IT FOR YOU: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Benchmarking end-user preferences for nucleic acid isolation and purification technologies and applications |
|
Assessed adoption across workflows such as PCR/qPCR, NGS, molecular diagnostics, infectious disease testing, oncology research, biobanking |
| Identifying outsourcing, collaboration, and partnership opportunities in nucleic acid isolation and purification workflow development |
|
Identified partners for workflow integration, automation, assay development, validation support |
| Country-specific regulatory, accreditation, and procurement insights for nucleic acid isolation and purification systems |
|
Assessed funding trends, public health initiatives, technology adoption for molecular diagnostics and genomics |
| Additional company profiling requirements for competitive intelligence |
|
Benchmarked players across automation, throughput, application coverage |
RECENT DEVELOPMENTS
- October 2025 : QIAGEN announced the placement of its 4,000th QIAcube Connect and reported that the total number of QIAcube family installations had approached 13,000. The company also reiterated its plans for the upcoming launches of QIAsymphony Connect, QIAsprint, and QIAmini.
- October 2025 : Merck introduced two new kits: the MagPrep Viral RNA Isolation Kit and the MagPrep cfDNA Isolation Kit. The cfDNA kit extracts cell-free DNA from blood samples for liquid biopsy, whereas the viral RNA kit isolates viral RNA from biological samples like nasal swabs.
- September 2025 : Thermo Fisher launched the MagMAX HMW DNA Kit for high-molecular-weight DNA extraction, designed for long-read sequencing applications and automated KingFisher workflows.
- October 2024 : Illumina launched the MiSeq i100 Series, positioning it as a simpler, faster benchtop sequencing platform for more labs.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Methodology
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global nucleic acid isolation and purification market. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of leading market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with primary research inputs to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the global nucleic acid isolation and purification market. The secondary sources used for this study include WHO Disease Statistics (Oncology, Genetic Disorders), CMS Clinical Laboratory Improvement Amendments (CLIA) Laboratory Lists, Association of Public Health Laboratories (APHL) List, Regional Forensic Laboratories list, State Office of Chief Medical Examiner (OCME) List, Biocluster List of Members (Massbio, NC Bio, CLSA), Organization for Economic Co-operation and Development (OECD) R&D Expenditure, National Animal Health Laboratory Network (NAHLN) laboratories List, Genome Canada Membership List, Genome Canada Laboratories Network, Canada Statistics Business Enterprise R&D Statistics, EudraGMP Sites, Biodeutschland Member List, European Federation of Pharmaceutical Industries and Associations (EFPIA) R&D Spending, European Union Drugs Agency (EUDA) Network of forensic and toxicological laboratories list, EudraGMP Sites, BioIndustry Association Member List, NHS Genomics Laboratories Hub, UK Health Security Agency's Laboratories List, FranceBiotech List, China Pharmaceutical Industry Association (CPIA) Member List, China Chinese Center for Disease Control and Prevention (CDC) National Institute for Viral Disease Control and Prevention (IVDC) Laboratories, Japan Pharmaceutical Manufacturers Association (JPMA) & Japanese Bankers Association (JBA) Statistics, NIID (National Institute of Infectious Diseases) reference labs, Indian Pharmaceutical Association (IPA) and Organisation of Pharmaceutical Producers of India (OPPI) Membership List, Brazilian Association of Research-Based Pharmaceutical Industries (Interfarma), Fiocruz Genomic Network Institutes, KAUST Research and Technology Park Companies, Saudi Public Health Authority (Weqaya) National Reference Laboratory System, African Biomedical Engineering Consortium List, Africa CDC Pathogen Genomics Initiative (Africa PGI) Sequencing Laboratories; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, professional associations. These sources were also used to obtain key information on major players, market classification, and segmentation aligned with industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
Following an initial assessment of the global nucleic acid isolation and purification market landscape through secondary research, comprehensive primary research was undertaken. This involved conducting in-depth interviews with market experts from the demand side, including stakeholders from pharmaceutical and biotechnology firms, CROs, CMOs, and academic and research institutions. Additionally, interviews were conducted with key supply-side participants, including C-suite and senior executives, product managers, and marketing and sales leaders from prominent manufacturers, distributors, and channel partners. The research covered six major geographical regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% of the primary interviews were conducted with supply-side participants, while 30% were conducted with demand-side experts. Data collection methods included structured questionnaires, email correspondence, online surveys, personal interviews, and telephonic discussions to comprehensively understand market dynamics.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both bottom-up and top-down approaches were used to estimate and validate the total size of the global nucleic acid isolation and purification market. These methods were also widely used to estimate the sizes of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- A list of the major global players operating in the nucleic acid isolation and purification market was generated.
- The revenues generated from their nucleic acid isolation and purification product portfolios have been determined through annual reports and secondary sources (including paid databases).
- The products were mapped according to the segments of the market. Percentage shares and splits were determined based on each segment's revenue contribution. This was verified using secondary sources and by industry experts.
- All assumptions, approaches, and individual shares/revenue estimates were validated through expert interviews.
Data Triangulation
After arriving at the market size from the estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, as applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Nucleic acid isolation and purification is a set of molecular biology techniques used for the extraction of DNA and RNA for use in downstream applications, such as sequencing, cloning, and polymerase chain reaction. These downstream applications are important parts of life science research, molecular diagnostics, forensics, and genetic engineering. The report defines the Nucleic acid isolation and purification market as the supplier revenue market for kits, reagents, and instruments used for method, application, type of nucleic acid, and type of samples as described below in the inclusions and exclusions.
Key Stakeholders
- OEMs, contract manufacturers, and distributors of nucleic acid isolation and purification kits, reagents, and instruments
- Start-ups, platform technology & service providers
- Diagnostic centers, government hospitals, and private clinics
- Pharmaceutical & biotechnology companies
- Contract research organizations and other service providers
- Government institutions & associations funding pharmaceutical & biotechnology R&D
- Venture capitalists and investors
- Research associations related to genomics
- Forensic laboratories
- Veterinary hospitals/clinics
- Food testing laboratories
Report Objectives
- To define, describe, and forecast the global nucleic acid isolation and purification market based on product, method, type, sample type, application, and end user
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets concerning individual growth trends, prospects, and contributions to the nucleic acid isolation and purification market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments concerning six main regions: North America, Europe, Asia Pacific, Latin America, Middle East, and Africa
- To profile the key players in the global nucleic acid isolation and purification market and comprehensively analyze their product portfolios, market positions, and core competencies
- To analyze competitive developments such as product approvals and launches, expansions, agreements, and collaborations in the nucleic acid isolation and purification market
- To benchmark players within the nucleic acid isolation and purification market using the company evaluation matrix framework, which analyzes market players based on various parameters within the broad categories of business and service strategy
Available customizations:
With the given market data, MarketsandMarkets offers customizations to meet your company's needs. The following customization options are available for this report:
Portfolio Assessment
- Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies.
Company Information
- Detailed analysis and profiling of additional market players (up to three).
Geographical Analysis
- A further breakdown of the Rest of Asia Pacific nucleic acid isolation and purification market into countries
- A further breakdown of the Rest of Europe nucleic acid isolation and purification market into countries
- A further breakdown of the Rest of Latin America nucleic acid isolation and purification market into countries
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This ReportPersonalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Nucleic Acid Isolation and Purification Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free CustomisationTESTIMONIALS
JAYANT RAJPUROHIT
Director of Market Insights, Data and Analytics
SFI Health,
Leading Pharmaceutical Companywww.sfihealth.com/
We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
BEATRIZ DE LA CALLE
Head of Commercial Analytics
Qualicaps,
Leading Pharmaceutical Companywww.qualicaps.com/
We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
Bob Williams,
Senior Director Business Development & Innovation
Bracco Diagnostics Inc.,
Italian Multinational in life sciences sector and a World Leader in imaging diagnosticsimaging.bracco.com/us-en
We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.
Cody Coonradt,
Market Development and Strategy Manager
3M Health Information Systems,
Leader in Health care Coding, Payment & Analytics Solutions.www.3m.com/3M/en_US/health-information-systems-us
The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.
Their customer first approach and high value engagement model, have given us great analysis and excellent value for money
Growth opportunities and latent adjacency in Nucleic Acid Isolation and Purification Market
Still Researching the
Nucleic Acid Isolation and Purification Ecosystem?
See the competitors, opportunities, and growth signals shaping it - instantly.
Generate 15+ consulting-grade strategic insights tailored to your growth question.
Alessia
Jun, 2026
After reviewing the Nucleic Acid Isolation and Purification Market report, I see the demand is being strongly shaped by expanding molecular diagnostics and I now better understand how clinical labs are prioritizing workflow efficiency over cost alone..
Julian
Jun, 2026
Going through the Nucleic Acid Isolation and Purification Market analysis helped me clarify the technical shift toward automated extraction platforms and silica membrane-based kits that are improving reproducibility in high-throughput testing..
Seraphina
Jun, 2026
From an investment perspective, the Nucleic Acid Isolation and Purification Market insights suggest I should closely watch reagent manufacturers and regional expansion in Asia-Pacific, where genomics adoption is accelerating faster than expected..